Schedule 13G ownership disclosure

Protagonist Therapeutics Inc

Security class unavailable · CUSIP: 74366E102

Event date: 2019-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
113,140
Percent of class
0.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-021728
Form type
SC 13G/A
Filer
Protagonist Therapeutics, Inc
CIK
CIK 1377121
Filed
Feb 14, 2020
Reporting period
Dec 31, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub